BOC Sciences company news

Home > News

News

Sep 25 2023 BOC Sciences Adds World Vaccine Congress Europe to Its 2023 Event Calendar

"End-to-End Support for Your Pharmaceutical Journey", with the commitment to researchers, BOC Sciences will attend the renowned World Vaccine Congress Europe in Barcelona, Spain, from 16 to 19 October. World Vaccine Congress Europe has become the world's largest and most established meeting dedicated to vaccines . It bring s together the professionals and companies that are shaping the future of vaccines and offer s the opportunity for quality networking and new business opportunities. BOC S..

Aug 28 2023 Fermentation Production of ADC Payloads

Targeted therapies have significantly advanced the field of cancer therapy, and among these, antibody-drug conjugates (ADCs) have emerged as a viable therapeutic strategy. ADCs increase efficacy and decrease systemic toxicity by fusing the potency of cytotoxic drugs with the specificity of monoclonal antibodies (mAbs). The manufacture of high-quality and stable payloads by fermentation techniques is an essential component of ADC development. What are ADC Payloads? The payloads, also known as..

Aug 28 2023 Bioconjugation Strategies for Enhancing Drug Delivery and Therapeutic Efficacy

In recent years, bioconjugation has emerged as a powerful strategy for improving drug delivery and enhancing therapeutic efficacy. By linking drugs to various biological entities, such as proteins, antibodies, nanoparticles, or targeting moieties, bioconjugation enables precise and targeted delivery of therapeutic agents to desired sites. This article aims to provide an overview of different bioconjugation strategies employed for various drug classes, highlighting their advantages, challenge..

Aug 28 2023 BOC Sciences Introduces a Novel XDC Bioconjugation Platform to Advance Biomedical Research

BOC Sciences, a leading supplier of research chemicals and custom services, has unveiled its innovative XDC b ioconjugation platform, providing a significant tool for drug delivery . The newly developed XDC b ioconjugation platform offered by BOC Sciences introduces a range of advanced technologies and optimized protocols, revolutionizing the process of linking compounds to biomolecules. By leveraging cutting-edge conjugation methods, targeting drug delivery solutions, and RNAi delivery syst..

Jul 10 2023 Fermentation for Small Molecules: a Special Offer from BOC Sciences

Owing to the comprehensive capabilities of identification, analysis, preservation, etc., BOC Sciences can offer small molecules that are fermented in the culture of living cells. These materials, different from the traditionally synthesized ones, are proved to be more cost-effective, thus better meeting downstream research needs. Fermentation is not a stranger to the pharmaceutical industry since synthetic biology has been intensively applied in the production of APIs for decades. Currently,..

Jul 10 2023 Carbohydrates of BOC Sciences Reveal Myriad Possibilities for Therapeutics

BOC Sciences updated several carbohydrates and derivatives in July 2020 and has kept a constant enlargement of product categories since then. Currently, it provides a full spectrum of carbohydrates that dramatically boost the research in Glycochemistry, Glycobiology, Glyco-analytics, and other Glycosciences. C arbohydrate -containing drugs are regarded as promising strategies in the treatment of various diseases . However, they occupy only a small portion of all the drugs on the market, with..

Jun 15 2023 BOC Sciences Confirms Bulk Offering of Pharmaceutical Impurities for Global Partners

In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards in bulk to satisfy unmet demands. Innovations in manufacturing processes, more complicated formulations, and increasingly complex global supply chains are just some of the factors making it more difficult for companies to assess and control impurities in drug substances and drug products. BOC Sciences is confident to e..

Jun 15 2023 BOC Sciences Ensures Secure and Rapid Delivery of Isotopically Labeled Materials for Drug Compound

BOC Sciences' radiochemists work closely with the worldwide drug compound research team s to deliver high-quality stable isotope labeled products as well as consulting and tailor-made services. "Whether clients require an internal standard for quantitative analysis in a clinical study, need to determine metabolic routes and rates, or desire an assay substrate molecule that releases a labeled product distinct from the endogenous product molecules present in a cell or tissue sample, BOC S..

Jun 15 2023 BOC Sciences Reports Strong Capabilities of CDMO Operations

BOC Sciences, one of the front-runner s in chemical material manufacturing and custom services for the full drug product lifecycle, today reported strong growth over the past year in its expanded contract development and manufacturing (CDMO) platform. Competition in the pharmaceutical market is fierce, so leveraging CDMO as a partner for strategic execution is critical. The rapidly growing market also demands a shift in capacity and a focus on smaller niche populations. The main task of BOC ..